Atlas Trials

Primary Breast Cancer

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primary Breast Cancer

RecordFirmDate
mULM to Support Breast Cancer Diagnosis and Therapy (NCT05445050)RWTH Aachen University2021-04-26
Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy (NCT04468113)Kliniken Essen-Mitte2020-05-14
Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3 (NCT04277338)Tomsk National Research Medical Center of the Russian Academy of Sciences2020-02-10
Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy (NCT03270007)Tao OUYANG2017-11-10
Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE) (NCT01779479)GBG Forschungs GmbH2013-02-01
Breast Cancer Proteomics and Molecular Heterogeneity (NCT01840293)Cancer Trials Ireland2013-02-01
Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy (NCT01019616)Tao OUYANG2011-03-04
Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER) (NCT04127019)Fudan University2010-06-01
Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy (NCT01314833)Fudan University2010-06-01
Effectiveness of the CHESS eHealth Cancer Support Intervention in Population-based Care (NCT01033162)University of Wisconsin, Madison2009-11-01
Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer (NCT01049425)Women's Cancer Study Group GmbH2009-02-05
Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel (NCT00527449)Klinikum Weissenfels2006-05-01
Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow (NCT00172068)Novartis Pharmaceuticals2002-01-01
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer (NCT00793377)GBG Forschungs GmbH

Track Primary Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.